ICUI Stock Recent News
ICUI LATEST HEADLINES
NEW YORK , April 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK CITY, NY / ACCESS Newswire / April 28, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI.
LOS ANGELES , April 28, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ: ICUI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
LOS ANGELES--(BUSINESS WIRE)--ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm.
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
NEW YORK, NY / ACCESS Newswire / April 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ICU Medical, Inc. ("ICU Medical, Inc.") (NASDAQ:ICUI) concerning possible violations of federal securities laws. On April 22, 2025, ICU Medical disclosed it had received a warning letter from the FDA citing unauthorized changes to two of its infusion pump products.
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ICU Medical, Inc. (Nasdaq: ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical, Inc. investment should contact the firm to learn more about how they might recover those losses.
SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2025 earnings release and conference call.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of ICU Medical, Inc. (“ICU Medical” or the “Company”) (NASDAQ: ICUI) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ICU MEDICAL, INC. (ICUI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by e.